Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
you're welcome dude. glad to help you out here
that's not the CEO that's Lisa Thompson writing this article and arguing.
$NETE - following a SEC document from 06/12/15 "based on 46,186,962 shares of Common Stock issued and outstanding as of May 14, 2015"
so, the CEO couldn't have said back in march there are 80 millions outstanding shares. FWIW
i don't doubt it might run hard the next few days, but i doubt that dilution is always a killer to the SP. there are some more forces playing here ABIO and there NETE. imo
the stockholder meeting was 06/22/15 and they voted for a possible RS within a year from that date. cam come rather quick - it depends on the goodwill of the ABIO board
http://biz.yahoo.com/e/150623/abio8-k.html
they did a Form D small offering again on 06/25/15 offering
Total Offering Amount $ 51650404 USD
the buying of RA capital was within the first offering
"ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced the closing of the previously announced private placement financing with a select group of institutional investors, including lead investor Venrock, New Enterprise Associates (NEA), funds managed by Franklin Advisers, Inc., RA Capital Management, Tekla Life Sciences Investors and other institutional investors. ARCA received net proceeds of approximately $34 million from the sale of approximately 42 million units at a price of $0.8805 per unit. Each unit consists of one share of ARCA’s common stock and a warrant to purchase 0.40 shares of common stock with an exercise price of $0.8716. The warrants have a term of seven years and become exercisable 180-days after the closing date."
they voted for executin of a reverse split when the board thinks its necessary
"On June 22, 2015, ARCA biopharma, Inc. (the “Company”) held its 2015 Annual Meeting of Stockholders at which the Company’s stockholders voted upon (i) the election of Company nominees Dr. Raymond L. Woosley and Mr. Dan J. Mitchell, to the Company’s Board of Directors (the “Board”), each for a three-year term ending at the 2018 Annual Meeting of Stockholders, (ii) the ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015 and (iii) the authorization of the Company’s Board of Directors to, for a period of up to one-year, file an amendment to the Company’s restated certificate of incorporation to effect a reverse split of the Company’s Common Stock at a ratio in the range of 3:1 to 20:1, if, in the Board’s judgment, it is deemed necessary."
some flags to consider here too
they announced an offering few days before the filing of RA capital. looks like it was bought through the offering.
Peter Kolchinsky buying 5M shares here through his fund - is it dilution now ...? why does the price go up if it's dilution? why buying after the company diluted their O/S? no offense here, but if buyin shares directly from a company and not on the open market is dilution in your eyes - ABIO just has diluted shareholders.
"As of May 27, 2015, each of the Reporting Persons may be deemed to have beneficial ownership of 4.291.391 shares of Common Stock which such shares of Common Stock representing beneficial ownership of approximately 8.5% of the common Stock based on 46,186,962 shares of Common Stock issued and outstanding as of May 14, 2015 , as reported by the Company, plus 4,291,391 shares of common Stock Beneficially owned by Meglenta Enterprises Inc."
http://www.sec.gov/Archives/edgar/data/1499961/000101376215000607/sc13g0615maglenta_netelement.htm
i don't know how she comes up to 80M shares, but she's writing of fully diluted shares. so there are probably some warrants, options, convertible shares outstanding but not converted yet. the O/S now is around 50M shares and will get close to 56-57M shares if the $10.5M are finally converted. this figure is lacking the shares paid as interest per quarter in the future.
$NETE while i agree with you that the downward momentum in shareprice is concerning, this is a nice comprehension of the recent financing lacking your repeated mentioned 53M share dilution.
"The financing for this deal, which has already occurred is structured as follows:
On April 30, 2015, NETE sold $5.5 million of 5,500 shares of newly-issued Series A convertible preferred stock with a 9% dividend (and a default rate of 18%) with accelerated principal and dividend payments payable monthly in cash and/or shares of common stock through October, 2015. It matures April 20, 2017. It is convertible into common at $1.74 per share adding 3.16 million shares to the fully diluted number. On May 13, 2015, certain holders of this preferred stock converted 92 preferred shares into 139,713 shares of common stock. The dividend it expects to be paid in common stock not cash and will add approximately 1 million shares per quarter to the outstanding.
On April 30, 2015, NETE also sold $5 million of 7% senior convertible notes convertible into common and warrants and mature on April 30, 2018. The notes are convertible at $1.624 per share. The warrants have a term of three years and an exercise price of $1.74 per share."
http://finance.yahoo.com/news/nete-post-q1-financing-acquire-171500109.html
lol
talking about LIQD - broke the 50SMA some days ago and holding it. large volume on up days, low on down days... possibly something cooking there.
don't forget the large stake novartis took in BLRX @$2.00. they are not in here for some pennies, imo.
SNGX - yes indeed. i told you i had the shares a really long time.
you're welcome. they had a trial failure and the stock took a nosedive. i did have those shares a really long time. lol.
no it's not. i got rid of my last shares with an average of $5.67 (and that was not the all time high) post R/S on this spike this morning. big loss went a little smaller. probably will get in again here when it has cooled down a bit. also the TAs are showing overbought right now.
remember ACAD trading the days before the data release. it went down from $2.40 to $1.7s in a few sessions but on low to average volume.
i shitted my pants an sold 8k out of 10k shares with an average of $2.2s for a loss - the rest is history
$NETE - he sold due to his own trading plan like he did some times before
Explanation of Responses:
1. Sold pursuant to 10b5-1 Plan.
http://www.investopedia.com/terms/r/rule-10b5-1.asp
$LIQD seems ready for next leg up if it breaks $0.26. ask looks thin. volume is nice
$NETE 100k shares bid @$0.47 - bottom in here or fake wall?
i'm really sorry matt. my dad left me three years ago. i still miss him. family and friends are most important in that situation. wish you the best.
fully agree
$NETE reiterated covering by SeeThruEquity with a $5+ price tag
http://finance.yahoo.com/news/seethruequity-issues-company-net-element-130000703.html
$NETE feiteratwd covering by SeeThroughEquity with a $5+ price tag
http://finance.yahoo.com/news/seethruequity-issues-company-net-element-130000703.html
following their last 10Q $NETE burned $1.6M and had ~$5M cash. assuming them selling shares at the 52w low to generate cash is ridiculous. what for? they could have waited for a much better price and more money if they just wanted to dilute. imo
though i have to admit that todays trading is a bit concerning to me. more than 4 million shares sold and mostly to the downside. i think we have to watch it really careful here.
matt, i did read it like i always do. i pointed out exactly the same some posts ago. GL
AF, i remember you writing similar things abot SQNS on your board and until now they did not dilute or R/S and the price went back up nice. so don't mislead other readers, please.
they are not sold, they are registered as an underlying of the senior convertible notes and the warrants. the price had to be determined as an average price of the last days share price and may vary when the notes finally are converted. just read the filing.
There are being registered under this registration statement an aggregate of up to 53,600,000 shares of Common Stock, which includes (i) shares of Common Stock issuable upon conversion of Senior Convertible Notes in the aggregate principal amount of $5,000,000 and interest of 7% per annum payable under certain conditions, due April 30, 2018 and any additional Senior Convertible Notes up to aggregate principal amount of $10,000,000 issuable pursuant to the Securities Purchase Agreement dated April 30, 2015 (collectively, the “Notes”) and (ii) shares of Common Stock issuable upon exercise of Registrant’s warrants to purchase such number of shares that equal 88% of the shares of Common Stock underlying the Notes (the “Warrants”). Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered such indeterminable number of additional shares of Common Stock, preferred stock, warrants, units and subscription rights as may be issued to prevent dilution resulting from share dividends, split-up, reverse split-up or similar events.
$NETE on the move. $0.655 now
$NETE may pop EOD - look at Level2
looks like that was the bottom ;)
you missed $CPXX +16.3%
i see your point, but i'm referring to the people buyin' millions of shares at $2 when the shareprice on NASDAQ was ~$1.20 at the same time. they probably saw something that made them think $2 is a good entry for $NETE
i actually wouldn't call selling shares 90% above the normal shareprice a dump.
$NETE nice presentation
http://www.sec.gov/Archives/edgar/data/1499961/000114420415033701/v411759_ex99-1.htm
$NETE i'm eyeing that 40k shares @$2.25 on the ask. they've been there for some days now. would like that exit as well
CSO exercised options for 55k shares @$2.25
pretty nice before data release